Unlocking the Power of High-Dimensional Simulations with STDE 
Otonomy to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...
Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Tilray, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), invites all stockholders of record...
Humacyte Presents Preclinical Results of Small-Diameter HAV™ for Use as a BTT Shunt in Pediatric Heart Disease at American Heart Association’s Scientific Sessions 2021
-- Patency and host cell remodeling of the HAV were observed in all study implants – -- Preclinical study is...
USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note
● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48%...
Genenta To Present Updated Phase I/II Data At Upcoming Scientific Congresses SNO AND ASH
MILAN, Italy and NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotechnology company pioneering the development of...
Aurora Spine Corporation Announces Third Quarter 2021 Financial Results
- Revenue of $2.9 million in quarter was second highest in company’s history and highest level in over two years....
Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy of Ophthalmology 2021 and American Uveitis Society Meetings
Investigational therapeutics injected via the SCS Microinjector® demonstrate positive clinical data in wet AMD, diabetic retinopathy, and choroidal melanoma in...
Immatics Announces Third Quarter 2021 Financial Results and Provides Business Update
Interim data update at SITC for ongoing ACTengine® IMA203 trial targeting PRAME demonstrated clinical responses across multiple solid tumor types...
“Retirement first” approach to employee benefits key to attracting talent in the economic recovery
New research from HOOPP and Common Wealth makes business case for better workplace retirement plansTORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE)...
Voyager Therapeutics to Present Preclinical Data from Vectorized Antibody Program at the 26th Society for Neuro-Oncology Annual Meeting
CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments...
Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia
Positive trend observed in transfusion-dependent subjects treated with higher dose tovinontrine for reduced transfusion burden Tovinontrine was generally well-tolerated in this...
ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC
ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional Facilities Under ConstructionRAMSEY, N.J. and BOCA RATON, Fla....
AIM ImmunoTech Provides Third Quarter 2021 Business Update
OCALA, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announces financial results for the third...
Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at the American Heart Association Scientific Sessions 2021
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32% in patients with prior PADDUBLIN,...
Progressive Care Reports Financial and Operational Highlights for Three and Nine Months Ended September 30, 2021
Net Income Up 137%, EBITDA up 136% Year Over Year. Gross Margins Jump to 30% as Third-Party Services and Testing...
PolyPid Appoints New Oncology Advisory Board Member
Company is Scheduled to Conduct Pre-IND Meeting with the U.S. FDA Later This Month and Potentially Initiate Phase 1/2 Clinical Trial of...
MediWound Reports Third Quarter 2021 Financial Results
Third Quarter Revenues of $6.4 Million; Year-to-Date 2021 Revenues Increased 21% Clarity on Regulatory Pathway for Resubmission of NexoBrid BLA,...
Lobe Sciences Sponsors the International Summit on Psychedelic Therapies for Mental Illness
The largest and most important Psychedelic Medicine Conference in the Southern HemisphereVancouver, British Columbia--(Newsfile Corp. - November 16, 2021) -...
Leveljump to Acquire Telehospital Corp.
Toronto, Ontario--(Newsfile Corp. - November 16, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
Awakn Life Sciences Signs MOU with NHS (Devon Partnership NHS Trust) and University of Exeter with a View of Increasing Access to Psychedelic-Assisted Psychotherapy in the UK
With a Focus on Bringing the KARE Phase II a/b Trial (Ketamine-Assisted Psychotherapy for Alcohol Use Disorder) into Phase IIIToronto,...